Prasad Rajalingamgari

Mayo Clinic in Arizona

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Mayo Clinic in Arizona

Research Subjects

Research Interests

Prasad Rajalingamgari has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

Vijay P. Singh
Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA
2 shared publications
Abdulrahman Abonofal
Department of Internal Medicine East Tennessee State University, Johnson City, TN, USA
1 shared publication
Anoop Narayana Pillai
Department of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, United States
1 shared publication
Bara El Kurdi
University of Texas Health, Department of Medicine, Division of Gastroenterology and Hepatology, San Antonio, USA
1 shared publication
Biswajit Khatua
Department of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, United States
1 shared publication
Bryce McFayden
Department of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, United States
1 shared publication

Latest Publications

Sort by

Website
Google Scholar
Cited by 4
- 1 July 2024
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
Buprenorphine affects the initiation and severity of interleukin-induced acute pancreatitis in mice
by Sarah Jahangir, Biswajit Khatua, Nabil Smichi, Prasad Rajalingamgari, Anoop Narayana Pillai, Megan J. Summers, Bryce McFayden, Sergiy Kostenko, Naomi M. Gades, Vijay P. Singh
Extended-release buprenorphine interferes with the initiation and progression of acute pancreatitis at multiple levels.
Website
Google Scholar
- 1 July 2024
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
Buprenorphine affects the initiation and severity of interleukin-induced acute pancreatitis in mice
by Sarah Jahangir, Biswajit Khatua, Nabil Smichi, Prasad Rajalingamgari, Anoop Narayana Pillai, Megan J. Summers, Bryce McFayden, Sergiy Kostenko, Naomi M. Gades, Vijay P. Singh
Extended-release buprenorphine interferes with the initiation and progression of acute pancreatitis at multiple levels.
Cited by 4
Website
Google Scholar
Cited by 11
- 2 November 2023
- Published by Elsevier in Pancreatology
NSAIDs do not reduce severity among post-ERCP pancreatitis patients
by Bara El Kurdi, Zaid Imam, Abdulrahman Abonofal, Sumbal Babar, Pir Shah, Rahul Pannala, Georgios Papachristou, Juan Echavarria, Sailaja Pisipati, Sarah Jahangir, et al.
Website
Google Scholar
- 2 November 2023
- Published by Elsevier in Pancreatology
NSAIDs do not reduce severity among post-ERCP pancreatitis patients
by Bara El Kurdi, Zaid Imam, Abdulrahman Abonofal, Sumbal Babar, Pir Shah, Rahul Pannala, Georgios Papachristou, Juan Echavarria, Sailaja Pisipati, Sarah Jahangir, et al.
Cited by 11

Prasad Rajalingamgari

Current Organizations / Institutes

Research Subjects

Research Interests

Prasad Rajalingamgari has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

Latest Publications

Buprenorphine affects the initiation and severity of interleukin-induced acute pancreatitis in mice

Buprenorphine affects the initiation and severity of interleukin-induced acute pancreatitis in mice

NSAIDs do not reduce severity among post-ERCP pancreatitis patients

NSAIDs do not reduce severity among post-ERCP pancreatitis patients